Assessment cycle 2026 Q3 — page 10
Documents ratified in the 2026 Q3 assessment cycle, which ran from 1 July 2026 to 30 September 2026 and was ratified on 18 September 2026.
Documents ratified
-
Assessment Committee member, analytical standards. Analytical Scientist, accredited testing laboratory
30 Jul 2026 -
Assessment Committee member, nephrology. Consultant Nephrologist
30 Jul 2026 -
Assessment Committee member, neuropsychiatric outcomes. Consultant Psychiatrist
30 Jul 2026 -
Assessment Committee member, respiratory and sleep. Consultant in Respiratory and Sleep Medicine
30 Jul 2026 -
Assessment Committee member, methods. Senior Research Fellow, evidence synthesis
30 Jul 2026 -
Director of the Institute. Compound Evidence Institute
30 Jul 2026 -
Head of Secretariat. Compound Evidence Institute
30 Jul 2026 -
Head of Evidence Management. Compound Evidence Institute
30 Jul 2026 -
Head of Analytical Assessment. Compound Evidence Institute
30 Jul 2026 -
Senior Assessment Officer, monographs. Compound Evidence Institute
30 Jul 2026 -
Senior Assessment Officer, trial abstracts. Compound Evidence Institute
30 Jul 2026 -
Senior Assessment Officer, syntheses. Compound Evidence Institute
30 Jul 2026 -
Assessment Officer, supplier dossiers. Compound Evidence Institute
30 Jul 2026 -
Publications and Corrections Officer. Compound Evidence Institute
30 Jul 2026 -
Registry and Sitemap Officer. Compound Evidence Institute
30 Jul 2026 -
Standing external reviewer, cardiovascular outcomes. Professor of Cardiovascular Medicine
30 Jul 2026 -
Standing external reviewer, pharmaceutics. Reader in Pharmaceutics
30 Jul 2026 -
Standing external reviewer, mass spectrometry. Head of Mass Spectrometry, academic core facility
30 Jul 2026 -
Standing external reviewer, endocrinology. Professor of Endocrinology
30 Jul 2026 -
Standing external reviewer, paediatrics. Consultant Paediatric Endocrinologist
30 Jul 2026 -
Standing external reviewer, observational evidence. Senior Lecturer in Pharmacoepidemiology
30 Jul 2026 -
Standing external reviewer, lived experience. Patient representative
30 Jul 2026 -
Standing external reviewer, analytical methods. Independent analytical consultant
30 Jul 2026 -
Standing external reviewer, trial methodology. Clinical Trials Unit, academic
30 Jul 2026 -
Standing external reviewer, regulatory science. Professor of Regulatory Science
30 Jul 2026 -
External reviewer, pharmaceutics. Academic nephrology unit
30 Jul 2026 -
External reviewer, peptide chemistry. Sleep and respiratory medicine service
30 Jul 2026 -
Comment-period correspondent, sports medicine and anti-doping. University department of hepatology
30 Jul 2026 -
External reviewer, evidence synthesis. Academic clinical pharmacology unit
30 Jul 2026 -
Submitted-evidence contributor, clinical biochemistry. Academic mass-spectrometry core facility
30 Jul 2026 -
Comment-period correspondent, microbiological quality. Primary-care research network
30 Jul 2026 -
Comment-period correspondent, health-technology assessment. University department of pharmacy practice
30 Jul 2026 -
Submitted-evidence contributor, public health. Community pharmacy practice, doctoral candidate
30 Jul 2026 -
Comment-period correspondent, clinical pharmacology. Academic biostatistics group
30 Jul 2026 -
External reviewer, patient and public involvement. Primary-care research network
30 Jul 2026 -
External reviewer, cardiovascular outcomes. Hospital microbiology and endotoxin testing service
30 Jul 2026 -
Comment-period correspondent, clinical pharmacology. Academic nephrology unit
30 Jul 2026 -
External reviewer, evidence synthesis. University department of public health
30 Jul 2026 -
External reviewer, endocrinology. University department of hepatology
30 Jul 2026 -
Submitted-evidence contributor, microbiological quality. Independent analytical consultancy
30 Jul 2026
page 10 of 14